secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001193125-23-032567
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical to report Q4/FY2022 results on Feb 23, 2023, provide 2023 guidance
--------------------------------------------------------------------------------

- Results due after market close on Thursday, Feb 23, 2023.
- Conference call at 1:30 p.m. PT (Feb 23) / 8:30 a.m. AEDT (Feb 24).
- Webcast available on ir.avitamedical.com; replay afterward.
- 2023 revenue guidance will be discussed on the call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523032567/0001193125-23-032567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523032567/d410703d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-032567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer